title: [Aspirin for secondary prevention of venous thromboembolism. WARFASA: far from being conclusive].
authors.forename: A
authors.initials: A
authors.lastname: Delluc
authors.forename: K
authors.initials: K
authors.lastname: Lacut
authors.forename: D
authors.initials: D
authors.lastname: Mottier
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D011655:Pulmonary Embolism / Q000139:chemically induced / Q000453:epidemiology / Q000209:etiology; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors; D055502:Secondary Prevention / Q000379:methods; D054556:Venous Thromboembolism / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D014859:Warfarin; D001241:Aspirin